These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9675352)

  • 1. Efficacy of topical treatment of pigmentation skin disorders with plant hydroquinone glucosides as assessed by quantitative color analysis.
    Clarys P; Barel A
    J Dermatol; 1998 Jun; 25(6):412-4. PubMed ID: 9675352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
    Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
    J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.
    Draelos ZD; Yatskayer M; Bhushan P; Pillai S; Oresajo C
    Cutis; 2010 Sep; 86(3):153-8. PubMed ID: 21049734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of topical hypopigmenting agents on solar lentigines of Asian women.
    Hermanns JF; Petit L; Piérard-Franchimont C; Paquet P; Piérard GE
    Dermatology; 2002; 204(4):281-6. PubMed ID: 12077522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
    Fabi SG; Goldman MP
    J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
    Bruce S
    J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
    Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
    J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whitening effect of L-ascorbate-2-phosphate trisodium salt on solar lentigos.
    Ishikawa Y; Niwano T; Hirano S; Numano K; Takasima K; Imokawa G
    Arch Dermatol Res; 2019 Apr; 311(3):183-191. PubMed ID: 30778667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.
    Espinal-Perez LE; Moncada B; Castanedo-Cazares JP
    Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxypodophyllotoxin reduces skin pigmentation of brown Guinea pigs.
    Choi H; Lee J; Shin HJ; Lee BG; Chang I; Hwang JS
    Planta Med; 2004 Apr; 70(4):378-80. PubMed ID: 15095159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized and placebo-controlled study to compare the skin-lightening efficacy and safety of lignin peroxidase cream vs. 2% hydroquinone cream.
    Mauricio T; Karmon Y; Khaiat A
    J Cosmet Dermatol; 2011 Dec; 10(4):253-9. PubMed ID: 22151932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment of hyperpigmentation disorders.
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S153-8. PubMed ID: 23522631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
    Callender VD
    J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone.
    Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2013 Jan; 12(1):52-8. PubMed ID: 23377328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytic quantification of solar lentigines lightening by a 2% hydroquinone-cyclodextrin formulation.
    Petit L; Piérard GE
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):546-9. PubMed ID: 12941090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?
    Tse TW
    J Dermatolog Treat; 2010 Sep; 21(5):272-5. PubMed ID: 20095963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents.
    Dadzie OE; Petit A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):741-50. PubMed ID: 19470077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.